Roughly half of Parkinson\u2019s patients suffer from frightening extracampine hallucinations (EH). Unusually high dopamine levels are usually responsible. In many cases, these hallucinations of animals or deceased individuals are extremely unsettling and almost debilitating. Parkinson\u2019s hallucinations often touch almost every sensory nerve. Patients do not simply see things that are not there. These patients with hallucinations sometimes see, hear, taste, and smell things that are not there.<\/p>\n
Despite the nature and scope of the problem, there was no effective EH treatment until the Food and Drug Administration hastily approved Nuplazid in 2016. By 2017, sales eclipsed $125 million. Nuplazid\u2019s maker, San Diego-based Acadia Pharmaceuticals, expects sales to double in 2018. But there are serious concerns about the drug\u2019s effectiveness, and more importantly, its seguridad<\/a>.<\/p>\n Congress created the FDA\u2019s controversial expedited approval avenues to essentially short-circuit the agency\u2019s mission. Instead of taking the time necessary to help ensure safety and effectiveness, industry insiders can take advantage of legal loopholes to rush potentially unsafe drugs to market. If the FDA process fails to protect patients, aggressive and experienced Abogados de Napoli Law<\/a> tomar la holgura. Luchamos por la compensaci\u00f3n m\u00e1xima en estos casos de demanda de Nuplazid. Adem\u00e1s, tenemos los recursos para ayudarle. Las v\u00edctimas de malas drogas pueden confiar en Napoli Law para que act\u00fae como una voz fuerte tanto en la sala del tribunal como en la mesa de negociaciones.<\/p>\n <\/p>\n Nuplazid (Pimavanserin) es un medicamento oral. A $100 por dosis, puede costar f\u00e1cilmente a los pacientes de Parkinson $30,000 al a\u00f1o. Nuplazid es tambi\u00e9n una droga muy poderosa. Debido a que la EH afecta tantos sentidos diferentes, el medicamento debe afectar tanto al cerebro como a los sentidos de diferentes maneras.<\/p>\n Algunos efectos secundarios comunes incluyen:<\/strong><\/p>\n <\/p>\n Depending on the patient, these mild to moderate side-effects usually dissipate once the body adjusts to the medicine.<\/p>\n The potential serious side effects of this powerful medication are what really concerns doctors and other researchers. These serious and possibly fatal side effects include:<\/p>\n Otros posibles efectos secundarios incluyen erupciones cut\u00e1neas graves, fatiga excesiva, opresi\u00f3n en la garganta e infecciones del tracto urinario. Hasta ahora, Nuplazid se ha relacionado con m\u00e1s de 240 muertes. Esa es una cantidad astron\u00f3mica de muertes potenciales, dado que Pimavanserin solo ha estado disponible desde 2016.<\/p>\n <\/p>\n En promedio, las nuevas drogas pasan alrededor de una docena de a\u00f1os en el tuber\u00eda de aprobaci\u00f3n<\/a>. This area has been a bone of contention for years. Safety advocates claim that the time delay helps ensure that new drugs are safe.<\/p>\n Meanwhile, industry lobbyists have loudly complained that the proceso<\/a> is too long. A new drug patent usually lasts twenty years. The clock begins ticking when the drug is discovered and not when it is available for sale. So, drug makers may have only about eight years to recoup their extensive development costs, which could exceed $2.5 billion, and show a healthy profit.<\/p>\n Congress eventually listened to well-paid lobbyists as opposed to safety advocates and revised the approval process. But rather than addressing the issue directly, lawmakers sidestepped the question. They created two controversial approval shortcuts.<\/p>\n Incluso el proceso de aprobaci\u00f3n normal no garantiza la seguridad. La FDA recibe una parte sustancial de su presupuesto de la industria farmac\u00e9utica y de dispositivos m\u00e9dicos. Adem\u00e1s, para cuando la lenta FDA emita un retiro, muchas personas ya han resultado gravemente heridas.<\/p>\n <\/p>\n Nuplazid claims are very complex. They are theoretically easy to win, but very difficult to win in practice.<\/p>\n The burden of proof in these tort cases is usually a preponderance of the evidence, a legal term which means \u201cmore likely than not.\u201d If the scales of justice tip ever so slightly in the plaintiff\u2019s favor, the plaintiff prevails on that particular element. This is the lowest standard of proof in the law.<\/p>\n These cases almost always require expert witnesses. To evaluate these witnesses, New York courts use the more well-established est\u00e1ndar de fre\u00edr<\/a>. En general, sus opiniones solo deben ser razonables para que puedan testificar ante el jurado. Otros estados utilizaron el est\u00e1ndar Daubert m\u00e1s intenso.<\/p>\n <\/p>\n pharmaceutical and medical device companies have nearly unlimited resources. They hire top professional witnesses who testify that the device or drug is entirely safe. Furthermore, these cases are based on inductive reasoning (a limited amount of information) as opposed to deductive reasoning (a large body of data).<\/p>\n Therefore, to obtain fair compensation in these cases, victim\/plaintiffs and their family members need tenacious and highly-skilled attorneys.<\/p>\n\u00bfQu\u00e9 es Nuplazid?<\/h2>\n
\n
\n
El proceso de aprobaci\u00f3n de la FDA<\/h2>\n
\n
Su reclamo por da\u00f1os y perjuicios<\/h2>\n
Presentar una demanda de Nuplazid<\/h2>\n